4.7 Article

Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression

Journal

JOURNAL OF PATHOLOGY
Volume 224, Issue 3, Pages 309-321

Publisher

WILEY
DOI: 10.1002/path.2896

Keywords

CYLD; DKK2; skin cancer; cylindroma; epigenetics

Funding

  1. Newcastle Healthcare Charities Trust
  2. North East Skin Research Fund
  3. Breakthrough Breast Cancer
  4. Medical Research Council
  5. Medical Research Council [G0701367] Funding Source: researchfish
  6. National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish
  7. MRC [G0701367] Funding Source: UKRI

Ask authors/readers for more resources

Patients carrying heterozygous germline truncating mutations in the CYLD gene develop multiple primary hair follicle-related tumours. A highly patterned tumour, termed cylindroma, and a highly disorganized tumour, termed spiradenoma, may both develop in the same patient. Furthermore, histological features of both tumour types have been described within the same tumour specimen. We used three-dimensional computer-aided reconstruction of these tumours to demonstrate contiguous growth of cylindromas into spiradenomas, thus suggesting a transition between the two tumour types. To explore factors that may influence cutaneous tumour patterning, genome-wide transcriptomic analysis of 32 CYLD-defective tumours was performed. Overexpression of the Wnt/beta-catenin signalling pathway was observed relative to normal perilesional tissue. Morphometric analysis was used to investigate the relationship between Wnt pathway-related gene expression and tumour organization. This revealed an association between reduced Dickkopf 2 (DKK2-a negative regulator of the Wnt/beta-catenin signalling pathway) expression and loss of tumour patterning. Reduced DKK2 expression was associated with methylation of the DKK2 gene promoter in the majority of tumour samples assayed. RNA interference-mediated silencing of DKK2 expression in cylindroma primary cell cultures caused an increase in colony formation, cell viability, and anchorage-independent growth. Using these data, we propose a model where epigenetic programming may influence tumour patterning in patients with CYLD mutations. Copyright (C) 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available